BD (NYSE:BDX) announced today that it appointed Matthew Sassone as worldwide president of its Pharmacy Automation business. Sassone now leads the global business within the BD Medication Management Solutions business unit. His appointment goes into effect immediately. In the role, Sassone’s responsibilities include driving global strategy, performance and growth for Pharmacy Automation as part of […]
BD
BD, Wellstar collab on medication management
BD (NYSE:BDX) announced that it entered into a strategic partnership with Wellstar Health System to enhance medication delivery. Through the collaboration, Wellstar plans to build a more connected approach to medication management across its healthcare system. It plans to combine the Pyxis Pro medication dispensing technologies with Alaris infusion systems. Adopting the new technologies provide […]
BD launches Pyxis medication dispensing tech in Europe
BD (NYSE:BDX) announced today that it launched its Pyxis Pro Dispensing Solution and Incada Connected Care Platform in Europe. The next-generation medication dispensing system combines advanced automation and AI insights to modernize medication management. It helps reduce disruptions and improve efficiency while helping clinicians spend more time on patient care. Franklin Lakes, New Jersey-based BD […]
BD, Ypsomed to develop new syringe for biologics
BD (NYSE: BDX) and Ypsomed recently announced they will expand their collaboration through the development of a 5.5 ml version of BD’s Neopak XtraFlow glass prefillable syringe. The new BD syringe is presently in development and will undergo comprehensive testing to ensure its compatibility with Ypsomed’s YpsoMate 5.5 autoinjector platform. Syringe samples for feasibility studies […]
BD to invest $110M to support prefilled syringe production, pharma supply chain
BD (NYSE:BDX) announced today that it invested $110 million to expand its production of prefillable syringes in Columbus, Nebraska. Franklin Lakes, New Jersey-based BD aims to expand prefillable syringe production to accelerate biologic and GLP-1 drug delivery and support pharmaceutical reshoring in the U.S. The investment brings the company’s Neopak glass prefillable syringe production to […]
BD expands Alaris recall after identifying new potential issue
BD (NYSE:BDX) announced that it expanded its Class I voluntary recall for its Alaris Pump Module model 8100 infusion system. The expansion builds on a voluntary recall expanded earlier this year, informing customers of worst-case performance instances. Under certain cases, the pump, when used with a subset of compatible infusion sets, fails to perform as […]
BD to invest $35M to expand Nebraska syringe manufacturing
BD (NYSE: BDX) announced today that it plans to invest more than $35 million in U.S.-based prefilled flush syringe manufacturing. The company expects to add approximately 50 new jobs, expanding the manufacturing at its Columbus, Nebraska, facility. BD says it aims to increase the resiliency of the U.S. healthcare system through its latest syringe manufacturing […]
BD announces first pharma-sponsored clinical trial for wearable injector
BD (NYSE:BDX) today announced the first pharma-sponsored combination product clinical trial using its wearable injector technology. The study uses the BD Libertas wearable injector for the subcutaneous delivery of complex biologics. The company said it represents a significant advancement in accelerating innovation in drug-device combination products. It could provide greater flexibility for patients, including potential […]
BD issues voluntary recall on certain Alaris infusion pump modules
BD (NYSE:BDX) announced a voluntary recall related to certain Alaris and Alaris infusion pump modules. Affected Alaris products may have been serviced with previously recalled bezel kit assemblies. BD in 2019 recalled those kit assemblies manufactured between April 2011 and June 2017. They should not be used for service with the Alaris and Alaris Pump […]
BD files patent infringement lawsuit against Baxter over infusion pump tech
BD (NYSE:BDX) filed a lawsuit in a U.S. District Court alleging patent infringement by Baxter (NYSE:BAX) related to infusion pump technology. The company filed its complaint in the U.S. District Court for the District of Delaware on May 12, 2025. BD’s complaint singles out six specific patents: the “180,” “058,” “880,” “868,” “414,” and “703” […]
